CN1852990B - 确定样本中核酸数量的方法 - Google Patents
确定样本中核酸数量的方法 Download PDFInfo
- Publication number
- CN1852990B CN1852990B CN2004800068992A CN200480006899A CN1852990B CN 1852990 B CN1852990 B CN 1852990B CN 2004800068992 A CN2004800068992 A CN 2004800068992A CN 200480006899 A CN200480006899 A CN 200480006899A CN 1852990 B CN1852990 B CN 1852990B
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- reaction
- sample
- luciferase
- light emission
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 170
- 150000007523 nucleic acids Chemical class 0.000 title claims description 184
- 102000039446 nucleic acids Human genes 0.000 title claims description 178
- 108020004707 nucleic acids Proteins 0.000 title claims description 171
- 238000006243 chemical reaction Methods 0.000 claims description 241
- 108060001084 Luciferase Proteins 0.000 claims description 102
- 239000005089 Luciferase Substances 0.000 claims description 101
- 230000003321 amplification Effects 0.000 claims description 88
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 88
- 230000008859 change Effects 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 19
- 238000003556 assay Methods 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 16
- 102000004523 Sulfate Adenylyltransferase Human genes 0.000 claims description 15
- 108010022348 Sulfate adenylyltransferase Proteins 0.000 claims description 15
- 238000005516 engineering process Methods 0.000 claims description 15
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 13
- 230000005764 inhibitory process Effects 0.000 claims description 11
- 238000005259 measurement Methods 0.000 claims description 11
- 238000005415 bioluminescence Methods 0.000 claims description 10
- 230000029918 bioluminescence Effects 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 230000009467 reduction Effects 0.000 claims description 10
- 238000005382 thermal cycling Methods 0.000 claims description 10
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 7
- 238000004020 luminiscence type Methods 0.000 claims description 7
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 6
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 230000001717 pathogenic effect Effects 0.000 claims description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229960003636 vidarabine Drugs 0.000 claims description 2
- 238000007422 luminescence assay Methods 0.000 claims 2
- 230000010558 Gene Alterations Effects 0.000 claims 1
- 238000003759 clinical diagnosis Methods 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 230000026676 system process Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 121
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 57
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 38
- 108020004414 DNA Proteins 0.000 description 31
- 238000012544 monitoring process Methods 0.000 description 26
- 238000003752 polymerase chain reaction Methods 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 17
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 230000007423 decrease Effects 0.000 description 12
- 230000000630 rising effect Effects 0.000 description 12
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 10
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 238000006722 reduction reaction Methods 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 230000015556 catabolic process Effects 0.000 description 9
- 238000006731 degradation reaction Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 208000033147 Parenteral nutrition-associated cholestasis Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 6
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000004451 qualitative analysis Methods 0.000 description 6
- 238000004445 quantitative analysis Methods 0.000 description 6
- 238000013016 damping Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 238000001502 gel electrophoresis Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 4
- 241000254064 Photinus pyralis Species 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 108091093088 Amplicon Proteins 0.000 description 3
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 238000007397 LAMP assay Methods 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- 101150057615 Syn gene Proteins 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229950006790 adenosine phosphate Drugs 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- LIYGYAHYXQDGEP-UHFFFAOYSA-N firefly oxyluciferin Natural products Oc1csc(n1)-c1nc2ccc(O)cc2s1 LIYGYAHYXQDGEP-UHFFFAOYSA-N 0.000 description 3
- 238000011901 isothermal amplification Methods 0.000 description 3
- JJVOROULKOMTKG-UHFFFAOYSA-N oxidized Photinus luciferin Chemical compound S1C2=CC(O)=CC=C2N=C1C1=NC(=O)CS1 JJVOROULKOMTKG-UHFFFAOYSA-N 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 230000006819 RNA synthesis Effects 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- -1 and in an embodiment Proteins 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000019635 sulfation Effects 0.000 description 2
- 238000005670 sulfation reaction Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- PCDQPRRSZKQHHS-XVFCMESISA-N CTP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-XVFCMESISA-N 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000007421 fluorometric assay Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000659 freezing mixture Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229960004400 levonorgestrel Drugs 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001921 nucleic acid quantification Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035911 sexual health Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0300802.6 | 2003-01-14 | ||
| GBGB0300802.6A GB0300802D0 (en) | 2003-01-14 | 2003-01-14 | Method for detecting DNA polymerisation |
| PCT/GB2004/000127 WO2004062338A2 (en) | 2003-01-14 | 2004-01-14 | Method for determining the amount of template nucleic acid present in a sample |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1852990A CN1852990A (zh) | 2006-10-25 |
| CN1852990B true CN1852990B (zh) | 2010-08-18 |
Family
ID=9951119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2004800068992A Expired - Lifetime CN1852990B (zh) | 2003-01-14 | 2004-01-14 | 确定样本中核酸数量的方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7371545B2 (da) |
| EP (1) | EP1585836B1 (da) |
| JP (1) | JP4521581B2 (da) |
| CN (1) | CN1852990B (da) |
| AT (1) | ATE372392T1 (da) |
| AU (1) | AU2004204396B2 (da) |
| CA (1) | CA2513073C (da) |
| CY (1) | CY1107021T1 (da) |
| DE (1) | DE602004008740T2 (da) |
| DK (1) | DK1585836T3 (da) |
| ES (1) | ES2295815T3 (da) |
| GB (1) | GB0300802D0 (da) |
| PT (1) | PT1585836E (da) |
| WO (1) | WO2004062338A2 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002367744A1 (en) | 2001-07-03 | 2003-10-27 | The Board Of Trustees Of The Leland Stanford University | Bioluminescence regenerative cycle (brc) for nucleic acid quantification |
| GB0300802D0 (en) | 2003-01-14 | 2003-02-12 | Murray James A H | Method for detecting DNA polymerisation |
| GB0416944D0 (en) | 2004-07-29 | 2004-09-01 | Lumora Ltd | Method for determining the amount of template nucleic acid present in a sample |
| GB0516455D0 (en) * | 2005-08-10 | 2005-09-14 | Lumora Ltd | pH tolerant luciferase |
| JP4782528B2 (ja) * | 2005-10-04 | 2011-09-28 | 株式会社日立製作所 | 塩基配列決定方法と試薬 |
| US20090215050A1 (en) | 2008-02-22 | 2009-08-27 | Robert Delmar Jenison | Systems and methods for point-of-care amplification and detection of polynucleotides |
| GB0812862D0 (en) | 2008-07-14 | 2008-08-20 | Lumora Ltd | Nucleic acid amplification |
| JP2010161935A (ja) * | 2009-01-13 | 2010-07-29 | Fujifilm Corp | 核酸増幅反応におけるばらつきを低減する方法 |
| US9677981B2 (en) | 2013-03-15 | 2017-06-13 | 3M Innovative Properties Company | Sample concentrator and method of use |
| WO2016011280A1 (en) | 2014-07-16 | 2016-01-21 | Tangen Biosciences, Inc. | Isothermal methods for amplifying nucleic acid samples |
| WO2016073353A1 (en) | 2014-11-03 | 2016-05-12 | Tangen Biosciences, Inc. | Apparatus and method for cell, spore, or virus capture and disruption |
| CN106701966B (zh) * | 2017-01-20 | 2020-12-11 | 东南大学 | 基于分析pcr副产物焦磷酸的病原微生物快速检测方法 |
| US20200340038A1 (en) * | 2019-04-25 | 2020-10-29 | Nephros Inc. | Portable System and Process Thereof to Rapidly Filter, Concentrate, and Detect Waterborne Pathogens |
| US11891662B2 (en) | 2019-12-02 | 2024-02-06 | Talis Biomedical Corporation | Polynucleotides for amplification and detection of human beta actin |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001042496A2 (en) * | 1999-12-10 | 2001-06-14 | Pyrosequencing Ab | A method of assessing the amount of nucleic acid in a sample |
| US6258568B1 (en) * | 1996-12-23 | 2001-07-10 | Pyrosequencing Ab | Method of sequencing DNA based on the detection of the release of pyrophosphate and enzymatic nucleotide degradation |
| WO2002064830A2 (en) * | 2001-02-14 | 2002-08-22 | Cambridge University Technical Services Limited | Method for detecting dna polymerisation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994056A (en) | 1991-05-02 | 1999-11-30 | Roche Molecular Systems, Inc. | Homogeneous methods for nucleic acid amplification and detection |
| US20030104372A1 (en) | 1996-12-23 | 2003-06-05 | Pyrosequencing Ab. | Allele specific primer extension |
| AU7813698A (en) | 1997-06-06 | 1998-12-21 | Nexstar Pharmaceuticals, Inc. | Nucleic acid detection |
| GB0021977D0 (en) * | 2000-09-07 | 2000-10-25 | Pyrosequencing Ab | Method of sequencing DNA |
| JP2002306180A (ja) * | 2001-04-16 | 2002-10-22 | Hitachi Ltd | 核酸塩基配列解析法および核酸塩基配列解析試薬キットおよび核酸塩基配列解析装置 |
| GB0111275D0 (en) | 2001-05-09 | 2001-06-27 | Secr Defence | Analytical method and kit |
| AU2002367744A1 (en) | 2001-07-03 | 2003-10-27 | The Board Of Trustees Of The Leland Stanford University | Bioluminescence regenerative cycle (brc) for nucleic acid quantification |
| US20040197793A1 (en) * | 2002-08-30 | 2004-10-07 | Arjang Hassibi | Methods and apparatus for biomolecule detection, identification, quantification and/or sequencing |
| GB0300802D0 (en) | 2003-01-14 | 2003-02-12 | Murray James A H | Method for detecting DNA polymerisation |
| EP1616027A4 (en) | 2003-04-14 | 2009-07-22 | Temasek Life Sciences Lab Ltd | DETECTION OF TARGET NUCLEIC ACID BY REACTION OF POLYMERASE, AND ENZYMATIC DETECTION OF FREE PYROPHOSPHATE |
-
2003
- 2003-01-14 GB GBGB0300802.6A patent/GB0300802D0/en not_active Ceased
-
2004
- 2004-01-14 WO PCT/GB2004/000127 patent/WO2004062338A2/en active IP Right Grant
- 2004-01-14 ES ES04701994T patent/ES2295815T3/es not_active Expired - Lifetime
- 2004-01-14 EP EP04701994A patent/EP1585836B1/en not_active Expired - Lifetime
- 2004-01-14 CA CA2513073A patent/CA2513073C/en not_active Expired - Lifetime
- 2004-01-14 PT PT04701994T patent/PT1585836E/pt unknown
- 2004-01-14 DE DE602004008740T patent/DE602004008740T2/de not_active Expired - Lifetime
- 2004-01-14 CN CN2004800068992A patent/CN1852990B/zh not_active Expired - Lifetime
- 2004-01-14 DK DK04701994T patent/DK1585836T3/da active
- 2004-01-14 JP JP2006500210A patent/JP4521581B2/ja not_active Expired - Lifetime
- 2004-01-14 AT AT04701994T patent/ATE372392T1/de active
- 2004-01-14 AU AU2004204396A patent/AU2004204396B2/en not_active Expired
- 2004-01-14 US US10/541,364 patent/US7371545B2/en not_active Expired - Lifetime
-
2007
- 2007-11-26 CY CY20071101505T patent/CY1107021T1/el unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6258568B1 (en) * | 1996-12-23 | 2001-07-10 | Pyrosequencing Ab | Method of sequencing DNA based on the detection of the release of pyrophosphate and enzymatic nucleotide degradation |
| WO2001042496A2 (en) * | 1999-12-10 | 2001-06-14 | Pyrosequencing Ab | A method of assessing the amount of nucleic acid in a sample |
| WO2002064830A2 (en) * | 2001-02-14 | 2002-08-22 | Cambridge University Technical Services Limited | Method for detecting dna polymerisation |
Non-Patent Citations (5)
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004204396A1 (en) | 2004-07-29 |
| CY1107021T1 (el) | 2012-09-26 |
| JP2006516891A (ja) | 2006-07-13 |
| CN1852990A (zh) | 2006-10-25 |
| JP4521581B2 (ja) | 2010-08-11 |
| WO2004062338A8 (en) | 2005-10-06 |
| ATE372392T1 (de) | 2007-09-15 |
| ES2295815T3 (es) | 2008-04-16 |
| DE602004008740D1 (de) | 2007-10-18 |
| US7371545B2 (en) | 2008-05-13 |
| EP1585836A2 (en) | 2005-10-19 |
| EP1585836B1 (en) | 2007-09-05 |
| GB0300802D0 (en) | 2003-02-12 |
| DK1585836T3 (da) | 2008-01-02 |
| DE602004008740T2 (de) | 2008-06-12 |
| CA2513073A1 (en) | 2004-07-29 |
| CA2513073C (en) | 2012-08-28 |
| WO2004062338A3 (en) | 2004-09-10 |
| PT1585836E (pt) | 2007-12-14 |
| US20060257874A1 (en) | 2006-11-16 |
| WO2004062338A2 (en) | 2004-07-29 |
| AU2004204396B2 (en) | 2010-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1852990B (zh) | 确定样本中核酸数量的方法 | |
| Kaltenboeck et al. | Advances in real‐time PCR: Application to clinical laboratory diagnostics | |
| CN101035908B (zh) | 确定样本中模板核酸数量的方法 | |
| CN102071251B (zh) | 一种pcr检测核酸的方法 | |
| US5049490A (en) | Quantitative determination of a DNA polymerase and a test kit useful in same | |
| CN105492455A (zh) | 利用通用报告物的数字测定 | |
| US20200140938A1 (en) | Reagents and methods for autoligation chain reaction | |
| CN103597093A (zh) | 作为荧光参考标准品的ddao化合物 | |
| EP1360330A2 (en) | Method for detecting dna polymerisation | |
| Peters et al. | Quantitative polymerase chain reaction-based assay with fluorogenic Y-chromosome specific probes to measure bone marrow chimerism in mice | |
| US20210388420A1 (en) | Method for detecting a plurality of short-chain nucleic acid in sample, combinatorial analysis kit, analysis kit supply management method | |
| Stengel et al. | High density labeling of polymerase chain reaction products with the fluorescent base analogue tCo | |
| EP3209798B1 (en) | Reagents and methods for isothermal chain reaction | |
| CN107267650A (zh) | 一种aldh2*2基因型检测试剂盒及其检测方法 | |
| Nelson et al. | Multiplexed, lateral flow, polymerase chain reaction (PCR) techniques for biological identification | |
| CN104328211A (zh) | PML-RARα融合基因的环介导等温扩增检测方法的引物和试剂盒 | |
| CN110846385A (zh) | 一种检测修复糖基化酶的生物传感器及其检测方法和应用 | |
| Jones | Internal Validation of Quantifiler Human Quantfilier Y Human male DNA Quantification Kits Using Applied Biosystems 7500 Real-Time PCR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LUMORA LTD Free format text: FORMER OWNER: TISI LAURENCE C.; APPLICANT Effective date: 20080425 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20080425 Address after: cambridge Applicant after: LUMORA LTD. Address before: Erie Applicant before: Tisi Laurence C. Co-applicant before: Murray James A. H. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20100818 |
|
| CX01 | Expiry of patent term |